The ICR is led by Chief Executive Professor Kristian Helin, known for his pioneering scientific discoveries in cancer epigenetics.
We are world leaders in identifying cancer genes, discovering cancer drugs and developing precision radiotherapy.
Together with our hospital partner The Royal Marsden NHS Foundation Trust, we are rated as one of the top centres for cancer research and treatment worldwide.
As well as being as world-class research institute, the ICR is a higher education institution and a member institution of the University of London. We came second-top in the league table of university research quality, impact and environment compiled from the most recent Research Excellence Framework (REF 2021).
The ICR has charitable status and relies on support from partner organisations, charities, donors and the general public.